The global prevalence of human fascioliasis: a systematic review and meta-analysis
Background: Fascioliasis is a parasitic zoonosis that can infect humans and be a source of significant morbidity. The World Health Organization lists human fascioliasis as a neglected tropical disease, but the worldwide prevalence of fascioliasis data is unknown. Objective: We aimed to estimate the...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-07-01
|
| Series: | Therapeutic Advances in Infectious Disease |
| Online Access: | https://doi.org/10.1177/20499361231185413 |
| _version_ | 1797783888333897728 |
|---|---|
| author | Luis Raúl Rosas-Hostos Infantes Guillermo Andres Paredes Yataco Yeimer Ortiz-Martínez Treana Mayer Angelica Terashima Carlos Franco-Paredes Esteban Gonzalez-Diaz Alfonso J. Rodriguez-Morales D. Katterine Bonilla-Aldana Lilian Vargas Barahona Alyssa A. Grimshaw Daniel B. Chastain Stefan Sillau Luis A. Marcos Andrés F. Henao-Martínez |
| author_facet | Luis Raúl Rosas-Hostos Infantes Guillermo Andres Paredes Yataco Yeimer Ortiz-Martínez Treana Mayer Angelica Terashima Carlos Franco-Paredes Esteban Gonzalez-Diaz Alfonso J. Rodriguez-Morales D. Katterine Bonilla-Aldana Lilian Vargas Barahona Alyssa A. Grimshaw Daniel B. Chastain Stefan Sillau Luis A. Marcos Andrés F. Henao-Martínez |
| author_sort | Luis Raúl Rosas-Hostos Infantes |
| collection | DOAJ |
| description | Background: Fascioliasis is a parasitic zoonosis that can infect humans and be a source of significant morbidity. The World Health Organization lists human fascioliasis as a neglected tropical disease, but the worldwide prevalence of fascioliasis data is unknown. Objective: We aimed to estimate the global prevalence of human fascioliasis. Data sources and methods: We performed a systematic review and prevalence meta-analysis. We used the following inclusion criteria: articles published in the English, Portuguese, or Spanish languages from December 1985 to October 2022 and studies assessing the prevalence of Fasciola in the general population with an appropriate diagnostic methodology, including longitudinal studies, prospective and retrospective cohorts, case series, and randomized clinical trials (RCTs). We excluded animal studies. Two reviewers independently reviewed the selected studies for methodological quality, performing critical standard measures from JBI SUMARI. A random-effects model was conducted of the summary extracted data on the prevalence proportions. We reported the estimates according to the GATHER statement. Results: In all, 5617 studies were screened for eligibility. Fifty-five studies from 15 countries were selected, including 154,697 patients and 3987 cases. The meta-analysis revealed a pooled prevalence of 4.5% [95% confidence interval (CI): 3.1–6.1; I 2 = 99.4%; T 2 = 0.07]. The prevalence in South America, Africa, and Asia was 9.0%, 4.8%, and 2.0%, respectively. The highest prevalence was found in Bolivia (21%), Peru (11%), and Egypt (6%). Subgroup analysis showed higher prevalence estimates in children, in studies from South America, and when Fas2-enzyme-linked immunosorbent assay (ELISA) was used as a diagnostic method. A larger study sample size ( p = 0.027) and an increase in female percentage ( p = 0.043) correlated with a decrease in prevalence. Multiple meta-regression showed a higher prevalence for hyperendemic than hypoendemic ( p = 0.002) or mesoendemic ( p = 0.013) regions. Conclusion: The estimated prevalence and projected disease burden of human fascioliasis are high. Study findings support that fascioliasis continues to be a globally neglected tropical disease. Strengthening epidemiological surveillance and implementing measures to control and treat fascioliasis is imperative in the most affected areas. |
| first_indexed | 2024-03-13T00:32:17Z |
| format | Article |
| id | doaj.art-bdd274e911ed46b299bf7ef2b9cbe239 |
| institution | Directory Open Access Journal |
| issn | 2049-937X |
| language | English |
| last_indexed | 2024-03-13T00:32:17Z |
| publishDate | 2023-07-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Infectious Disease |
| spelling | doaj.art-bdd274e911ed46b299bf7ef2b9cbe2392023-07-10T12:33:21ZengSAGE PublishingTherapeutic Advances in Infectious Disease2049-937X2023-07-011010.1177/20499361231185413The global prevalence of human fascioliasis: a systematic review and meta-analysisLuis Raúl Rosas-Hostos InfantesGuillermo Andres Paredes YatacoYeimer Ortiz-MartínezTreana MayerAngelica TerashimaCarlos Franco-ParedesEsteban Gonzalez-DiazAlfonso J. Rodriguez-MoralesD. Katterine Bonilla-AldanaLilian Vargas BarahonaAlyssa A. GrimshawDaniel B. ChastainStefan SillauLuis A. MarcosAndrés F. Henao-MartínezBackground: Fascioliasis is a parasitic zoonosis that can infect humans and be a source of significant morbidity. The World Health Organization lists human fascioliasis as a neglected tropical disease, but the worldwide prevalence of fascioliasis data is unknown. Objective: We aimed to estimate the global prevalence of human fascioliasis. Data sources and methods: We performed a systematic review and prevalence meta-analysis. We used the following inclusion criteria: articles published in the English, Portuguese, or Spanish languages from December 1985 to October 2022 and studies assessing the prevalence of Fasciola in the general population with an appropriate diagnostic methodology, including longitudinal studies, prospective and retrospective cohorts, case series, and randomized clinical trials (RCTs). We excluded animal studies. Two reviewers independently reviewed the selected studies for methodological quality, performing critical standard measures from JBI SUMARI. A random-effects model was conducted of the summary extracted data on the prevalence proportions. We reported the estimates according to the GATHER statement. Results: In all, 5617 studies were screened for eligibility. Fifty-five studies from 15 countries were selected, including 154,697 patients and 3987 cases. The meta-analysis revealed a pooled prevalence of 4.5% [95% confidence interval (CI): 3.1–6.1; I 2 = 99.4%; T 2 = 0.07]. The prevalence in South America, Africa, and Asia was 9.0%, 4.8%, and 2.0%, respectively. The highest prevalence was found in Bolivia (21%), Peru (11%), and Egypt (6%). Subgroup analysis showed higher prevalence estimates in children, in studies from South America, and when Fas2-enzyme-linked immunosorbent assay (ELISA) was used as a diagnostic method. A larger study sample size ( p = 0.027) and an increase in female percentage ( p = 0.043) correlated with a decrease in prevalence. Multiple meta-regression showed a higher prevalence for hyperendemic than hypoendemic ( p = 0.002) or mesoendemic ( p = 0.013) regions. Conclusion: The estimated prevalence and projected disease burden of human fascioliasis are high. Study findings support that fascioliasis continues to be a globally neglected tropical disease. Strengthening epidemiological surveillance and implementing measures to control and treat fascioliasis is imperative in the most affected areas.https://doi.org/10.1177/20499361231185413 |
| spellingShingle | Luis Raúl Rosas-Hostos Infantes Guillermo Andres Paredes Yataco Yeimer Ortiz-Martínez Treana Mayer Angelica Terashima Carlos Franco-Paredes Esteban Gonzalez-Diaz Alfonso J. Rodriguez-Morales D. Katterine Bonilla-Aldana Lilian Vargas Barahona Alyssa A. Grimshaw Daniel B. Chastain Stefan Sillau Luis A. Marcos Andrés F. Henao-Martínez The global prevalence of human fascioliasis: a systematic review and meta-analysis Therapeutic Advances in Infectious Disease |
| title | The global prevalence of human fascioliasis: a systematic review and meta-analysis |
| title_full | The global prevalence of human fascioliasis: a systematic review and meta-analysis |
| title_fullStr | The global prevalence of human fascioliasis: a systematic review and meta-analysis |
| title_full_unstemmed | The global prevalence of human fascioliasis: a systematic review and meta-analysis |
| title_short | The global prevalence of human fascioliasis: a systematic review and meta-analysis |
| title_sort | global prevalence of human fascioliasis a systematic review and meta analysis |
| url | https://doi.org/10.1177/20499361231185413 |
| work_keys_str_mv | AT luisraulrosashostosinfantes theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT guillermoandresparedesyataco theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT yeimerortizmartinez theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT treanamayer theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT angelicaterashima theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT carlosfrancoparedes theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT estebangonzalezdiaz theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT alfonsojrodriguezmorales theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT dkatterinebonillaaldana theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT lilianvargasbarahona theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT alyssaagrimshaw theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT danielbchastain theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT stefansillau theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT luisamarcos theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT andresfhenaomartinez theglobalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT luisraulrosashostosinfantes globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT guillermoandresparedesyataco globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT yeimerortizmartinez globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT treanamayer globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT angelicaterashima globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT carlosfrancoparedes globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT estebangonzalezdiaz globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT alfonsojrodriguezmorales globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT dkatterinebonillaaldana globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT lilianvargasbarahona globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT alyssaagrimshaw globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT danielbchastain globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT stefansillau globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT luisamarcos globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis AT andresfhenaomartinez globalprevalenceofhumanfascioliasisasystematicreviewandmetaanalysis |